Correlation Between Furukawa Electric and ANI Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Furukawa Electric and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Furukawa Electric and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Furukawa Electric Co and ANI Pharmaceuticals, you can compare the effects of market volatilities on Furukawa Electric and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Furukawa Electric with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Furukawa Electric and ANI Pharmaceuticals.

Diversification Opportunities for Furukawa Electric and ANI Pharmaceuticals

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Furukawa and ANI is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Furukawa Electric Co and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Furukawa Electric is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Furukawa Electric Co are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Furukawa Electric i.e., Furukawa Electric and ANI Pharmaceuticals go up and down completely randomly.

Pair Corralation between Furukawa Electric and ANI Pharmaceuticals

Assuming the 90 days horizon Furukawa Electric Co is expected to generate 1.24 times more return on investment than ANI Pharmaceuticals. However, Furukawa Electric is 1.24 times more volatile than ANI Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest  2,710  in Furukawa Electric Co on October 7, 2024 and sell it today you would earn a total of  1,090  from holding Furukawa Electric Co or generate 40.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Furukawa Electric Co  vs.  ANI Pharmaceuticals

 Performance 
       Timeline  
Furukawa Electric 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Furukawa Electric Co are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Furukawa Electric reported solid returns over the last few months and may actually be approaching a breakup point.
ANI Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ANI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, ANI Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Furukawa Electric and ANI Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Furukawa Electric and ANI Pharmaceuticals

The main advantage of trading using opposite Furukawa Electric and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Furukawa Electric position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.
The idea behind Furukawa Electric Co and ANI Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings